|
CDK8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.44839720614709E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.1273999994964E-07 |
| Normal-vs-Stage2 |
1.200210E-03 |
| Normal-vs-Stage3 |
1.63369318073592E-12 |
| Normal-vs-Stage4 |
1.214920E-04 |
| Stage1-vs-Stage2 |
6.594400E-01 |
| Stage1-vs-Stage3 |
1.53593999999702E-05 |
| Stage1-vs-Stage4 |
1.900400E-01 |
| Stage2-vs-Stage3 |
4.559700E-02 |
| Stage2-vs-Stage4 |
4.802000E-01 |
| Stage3-vs-Stage4 |
3.146000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.25900401215517E-11 |
| Normal-vs-AfricanAmerican |
1.758970E-03 |
| Normal-vs-Asian |
4.340600E-01 |
| Caucasian-vs-AfricanAmerican |
6.629400E-01 |
| Caucasian-vs-Asian |
2.584500E-03 |
| AfricanAmerican-vs-Asian |
3.824400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1180003023934E-10 |
| Normal-vs-Female |
2.41859998695304E-09 |
| Male-vs-Female |
9.532000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.383460E-04 |
| Normal-vs-Age(41-60Yrs) |
3.34739999996447E-06 |
| Normal-vs-Age(61-80Yrs) |
4.67847982577041E-13 |
| Normal-vs-Age(81-100Yrs) |
1.755300000017E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.569600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.757600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.005800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.402460E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.800020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.406000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.463800E-02 |
| Normal-vs-Grade 2 |
2.15300000050433E-08 |
| Normal-vs-Grade 3 |
3.51330076142631E-11 |
| Normal-vs-Grade 4 |
1.569660E-04 |
| Grade 1-vs-Grade 2 |
5.282200E-01 |
| Grade 1-vs-Grade 3 |
2.427000E-01 |
| Grade 1-vs-Grade 4 |
1.529980E-01 |
| Grade 2-vs-Grade 3 |
9.182400E-02 |
| Grade 2-vs-Grade 4 |
2.782800E-01 |
| Grade 3-vs-Grade 4 |
7.629400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.45680001395476E-09 |
| Normal-vs-ccB subtype |
3.85630000043768E-07 |
| ccA subtype-vs-ccB subtype |
8.388800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.07390000120478E-08 |
| Normal-vs-N1 |
6.255600E-03 |
| N0-vs-N1 |
5.369800E-01 |
|
|
